Every year, 2 Million Neonatal & 250,000 Maternal deaths occur during the intra-partum period globally. In India, more than 80% of deliveries occur with the assistance of staff nurses in a low resource healthcare setting, which lacks skilled healthcare workers and medical devices. There is a need for affordable & accurate solutions designed for low skilled healthcare workers, which would help them in accurate monitoring and decision support during the intra-partum period.
KEYAR is an affordable and super easy to use patch-based wearable maternal-fetal monitoring device for the intrapartum period, which also communicates with DAKSH intrapartum monitoring mobile application for intelligent alerts and remote monitoring. The product is for the staff nurses/midwives/doctors, which help them in monitoring the mother and fetus during labor phase. The intelligent alerts also help them in making early decisions, which eventually save lives during the labor phase.
The innovation empowers low skilled healthcare workers during the intra-partum period for better monitoring and decision making to prevent maternal & newborn mortality/morbidity. Till date, more than 30,000 pregnant women monitored during the intrapartum period using Janitri solutions.
India has approximately 69 million diabetic patients. About 30% of diabetics develop diabetic peripheral neuropathy, and half of those will develop foot ulcers due to their condition. The poor are significantly at risk because of inadequate management of their condition. There is a critical need for affordable diagnostic devices to enable mass screening of diabetic patients for peripheral neuropathy, as well as a need for affordable treatment options for diabetic foot ulcers.
Kadam is a medical device developed for the treatment of Diabetic Foot Ulcers. The medical equipment in the proposed therapy involves exposing the patient’s foot with diabetes to a constant stream of warm oxygen inside a disposable therapy bag. Kadam consists of a warmer unit and a therapy bag which is used along with an off the shelf oxygen concentrator.
The proposed diabetic foot ulcer treatment method & the medical equipment developed will reduce hospital admissions of patients with diabetic foot ulcers. Kadam can potentially prevent 2 Lakh amputation per year in India. It will drastically reduce the cost of treatment of diabetic foot ulcer compared to existing therapies or equipment used
Infectious diseases constitute nearly 50% of the disease burden in India and much higher than 50% in people at the base of the pyramid and children below the age of 5. Delay in diagnosis and late or inappropriate treatment increases the risk of complications, higher morbidity, and mortality and increased cost to the patient.
OmiX Labs is developing a novel technology platform that allows for DNA testing for pathogens, outside of laboratory settings. Analogous to the glucose strips and glucometer devices for glucose testing at home, the OmiX platform detects pathogen DNA present in a few drops of blood on a novel disposable biochip, with a proprietary enrichment and assay on the chip and a reader for DNA analysis.
The platform is designed to bring advances in molecular diagnosis and create access where there is none: mostly in lower-income groups who do not have access to laboratories and yet need early and accurate detection to have a better chance for cure.